Microrna Market Anticipated To Reach US$ 666.7 Mn By 2025

Global microRNA market is expected to witness robust growth during the forecast
period. This growth is expected to be primarily driven by increasing demand of
microRNA re-agents and kits for various applications that could eventually translate
into developing innovative therapeutic solutions for various difficult-to-treat
illnesses. According to the new report published by Persistence Market Research
titled, “MicroRNA Market: Global Industry Analysis (2012-2016) and Forecast
(2017-2025),” which tracks the performance of global microRNA market for the
period of eight years, i.e. 2017-2025, the global market is projected to register a
CAGR of 7.9% in terms of value during the forecast period. The market is anticipated
to be valued at US$ 666.7 Mn by 2025.
Global microRNA market is highly fragmented owing to presence of various
companies, especially domestic players creating immense price competition. Thermo
Fisher Scientific Inc. is the leader in the global microRNA market in terms of revenue
share in 2016 due to a wide product portfolio. Thermo Fisher Scientific Inc. grabbed
major market share as it offers both miRNA reagents and the hardware required for
carrying out theses assays. Thermo Fisher Scientific Inc. also offers microRNA
products specifically catering to the animal health and agriculture segment. Hence its
wide product range catering to different end-users makes it a market leader in the
microRNA market.
Illumina Inc., takes second position in the global microRNA market. The company
has microarray kits and library preparation kits for miRNA. Moreover, NGS of
miRNAs is coming into wider use and provides unmatched efficacy in discovering
and detecting miRNA. Agilent Technologies, Inc. follows Illumina Inc. with a market
share of 7.5%. The company manufactures microarrays and has recently developed a
new application for studying miRNAs by combining miRNA method with SurePrint
inkjet synthesis technology.
Global MicroRNA Market: Forecast by Region
Five regions have covered in this report such as North America, Latin America,
Europe, APAC and MEA. North America is the largest region in microRNA market,
which is estimated to represent US$ 140.3 Mn, or 38.7% share of the total market in
2017 and is projected to reach to US$ 245.9 Mn, or 36.9%, expanding at CAGR of
7.3% over the forecast period of 2017–2025. Europe is expected to be the second
most lucrative market, with attractiveness index of 1.3 during the forecast period.
Global MicroRNA Market: Key Players
Some of the key players operating in the global microRNA market are Illumina, Inc.,
F. Hoffmann-La Roche Ltd., Agilent Technologies, Bio-Rad Laboratories
Inc.,Sigma Aldrich Corp., Qiagen N.V, Thermo Fisher Scientific, Inc., HTG
Molecular Diagnostics, Inc., Bioline GmbH (A Meridian Life Science Company),
Rosetta Genomics Ltd., Dharmacon, a Horizon Discovery Group Co., BioVendor
— Laboratorní medicína a.s., Miltenyi Biotec, Kaneka Corporation
(Eurogentec), Abcam Plc, GeneCopoeia, Inc., Promega Corporation, New
England Biolabs, Inc., NanoString Technologies, Inc., and System Biosciences
Request sample report @
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com